Serotonin type 6
receptor (5-HT
6
R) has gained particular
interest as a promising target for treating cognitive deficits, given
the positive effects of its antagonists in a wide range of memory
impairment paradigms. Herein, we report on degradation of the 1
H
-pyrrolo[3,2-
c
]quinoline scaffold
to provide the 2-phenyl-1
H
-pyrrole-3-carboxamide,
which is devoid of canonical indole-like skeleton and retains recognition
of 5-HT
6
R. This modification has changed the compound’s
activity at 5-HT
6
R-operated signaling pathways from neutral
antagonism to inverse agonism. The study identified compound
27
that behaves as an inverse agonist of the 5-HT
6
R at the Gs and Cdk5 signaling pathways. Compound
27
showed high selectivity and metabolic stability and was brain penetrant.
Finally,
27
reversed scopolamine-induced memory decline
in the novel object recognition test and exhibited procognitive properties
in the attentional set-shifting task in rats. In light of these findings,
27
might be considered for further evaluation as a new cognition-enhancing
agent, while 2-phenyl-1
H
-pyrrole-3-carboxamide might
be used as a template for designing 5-HT
6
R inverse agonists.